These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3185288)

  • 1. Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men.
    Ettinger WH; Hazzard WR
    Metabolism; 1988 Nov; 37(11):1055-8. PubMed ID: 3185288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic disorders of serum lipoproteins in endotoxin-poisoned mice: the role of high density lipoprotein (HDL) and triglyceride-rich lipoproteins.
    Sakaguchi S
    Microbiol Immunol; 1982; 26(11):1017-34. PubMed ID: 6220193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females.
    Schaefer EJ; Foster DM; Zech LA; Lindgren FT; Brewer HB; Levy RI
    J Clin Endocrinol Metab; 1983 Aug; 57(2):262-7. PubMed ID: 6408108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
    Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
    Phillips NR; Havel RJ; Kane JP
    Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity.
    Magill P; Rao SN; Miller NE; Nicoll A; Brunzell J; St Hilaire J; Lewis B
    Eur J Clin Invest; 1982 Apr; 12(2):113-20. PubMed ID: 6807682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated apolipoprotein-B levels in corticosteroid-treated patients with systemic lupus erythematosus.
    Ettinger WH; Hazzard WR
    J Clin Endocrinol Metab; 1988 Sep; 67(3):425-8. PubMed ID: 3410932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipoprotein changes during abstinence in chronic alcoholics.
    Weidman SW; Beard JD; Sabesin SM
    Atherosclerosis; 1984 Aug; 52(2):151-66. PubMed ID: 6433939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a high cholesterol and saturated fat diet on serum high-density lipoprotein-cholesterol, apoprotein A-I, and apoprotein E levels in normolipidemic humans.
    Tan MH; Dickinson MA; Albers JJ; Havel RJ; Cheung MC; Vigne JL
    Am J Clin Nutr; 1980 Dec; 33(12):2559-65. PubMed ID: 6776798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interferon on plasma lipoproteins and on the activity of postheparin plasma lipases.
    Ehnholm C; Aho K; Huttunen JK; Kostiainen E; Mattila K; Pakkarainen J; Cantell K
    Arteriosclerosis; 1982; 2(1):68-73. PubMed ID: 6174110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two patterns of LDL metabolism in normotriglyceridemic patients with hypoalphalipoproteinemia.
    Vega GL; Grundy SM
    Arterioscler Thromb; 1993 Apr; 13(4):579-89. PubMed ID: 8466893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia.
    Carlson LA; Holmquist L; Nilsson-Ehle P
    Acta Med Scand; 1986; 219(5):435-47. PubMed ID: 3739751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.